Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series) Meeting Abstract


Authors: Tarhini, A. A.; Betof Warner, A.; Johnson, M.; Kang, B.; Nakasato, A.; Vance, M.; Ling, Y. L.; Tang, J.; Patel, J.
Abstract Title: Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series)
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S750
Language: English
ACCESSION: WOS:000573469101398
DOI: 10.1016/j.annonc.2020.08.1234
PROVIDER: wos
Notes: Meeting Abstract: 1111P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors